From: Genetic generalized epilepsy: factors associated with drug resistance polytherapy
Polytherapy | P value | OR | 95% C.I | |
---|---|---|---|---|
Lower | Upper | |||
Nocturnal seizures | 0.007 | 2.013 | 1.209 | 3.351 |
Number of seizure types | 0.917 | 0.983 | 0.705 | 1.369 |
Absence seizure | < 0.001 | 2.455 | 1.583 | 3.806 |
Cluster of seizures | 0.029 | 2.072 | 1.080 | 3.976 |
H\O CAE | 0.182 | 1.991 | 0.724 | 5.475 |
Seizure frequency (GTC) before treatment (number in year) | < 0.001 | 1.134 | 1.054 | 1.220 |
Dose of sodium valproate till first remission | < 0.001 | 1.002 | 1.002 | 1.003 |
Age at onset | 0.061 | 0.964 | 0.929 | 1.002 |
EEG focal features | 0.017 | 2.216 | 1.151 | 4.264 |
Active EEGs | 0.275 | 1.297 | 0.813 | 2.071 |
Catamenial seizures (female) | 0.043 | 3.511 | 1.041 | 11.835 |